[Embolic ischemic strokes]

Vnitr Lek. 2014 Dec;60(12):1040-9.
[Article in Czech]

Abstract

Treatment of acute phase of ischemic stroke is aimed to limit the amount of damage using reperfusion strategy and subsequently administration of treatment providing pharmacological secondary prevention of recurrence. The early aetiology diagnosis of stroke is crucial for effective secondary prevention as the highest risk of recurrence is within few weeks after stroke. Exclusion of cardiac and vascular source of embolism by imaging methods is an important part in management of patients with ischemic stroke. These embolic sources are categorized as high risk and states are associated with moderate or unclear risk.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cerebral Infarction / drug therapy
  • Cerebral Infarction / prevention & control
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Recurrence
  • Risk Factors
  • Secondary Prevention / methods*
  • Stroke / drug therapy*
  • Stroke / prevention & control*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator